The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells

Journal of Cellular Physiology
Young-Hee Kang, Su-Jae Lee

Abstract

Previously, we have shown that the release of AIF from mitochondria is required for As2O3-induced cell death in human cervical cancer cells, and that reactive oxygen species (ROS) is necessary for AIF release from mitochondria. In this study, we further investigated the role of MAPKs in ROS-mediated mitochondrial apoptotic cell death triggered by As2O3. As2O3-induced apoptotic cell death in HeLa cells was associated with activation and mitochondrial translocation of Bax, a marked phosphorylation of Bcl-2, reduction of Bcl-2 and Bax interaction, dissipation of mitochondrial membrane potential. Using small interfering RNA, reduced Bax expression effectively attenuated As2O3-induced mitochondrial membrane potential loss and apoptotic cell death. Moreover, the phosphorylation of Bcl-2 induced by As2O3 diminished its ability to bind to Bax. Treatment of cells with As2O3 activated both the p38 MAPK and JNK pathways. Mitochondrial translocation of Bax was completely suppressed in the presence of p38 MAPK inhibitor PD169316 or si-p38 MAPK. The As2O3-induced Bcl-2 phosphorylation was attenuated largely by JNK inhibition using SP600125 or si-JNK and to some extent by p38 MAPK inhibition with PD169316 or si-p38 MAPK. In addition, N-acetyl...Continue Reading

References

May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·S HaldarC M Croce
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·T SatoH G Wang
May 2, 1997·The Journal of Biological Chemistry·T ItoW S May
Aug 28, 1998·Science·D R Green, J C Reed
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·R K SrivastavaD L Longo
Jun 4, 1999·Progress in Biophysics and Molecular Biology·M H Cobb
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Sep 16, 1999·Cellular and Molecular Life Sciences : CMLS·L A Tibbles, J R Woodgett
Mar 31, 2000·Experimental Cell Research·B Antonsson, J C Martinou
May 10, 2000·Nature Medicine·G Kroemer, J C Reed
Jul 26, 2000·The Journal of Cell Biology·S GhatanR S Morrison
Oct 26, 2000·Nature·M O Hengartner
Oct 31, 2000·The Journal of Biological Chemistry·B GuoJ C Reed
Oct 31, 2000·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·L Bernstam, J Nriagu
Mar 30, 2001·The Journal of Biological Chemistry·N KeJ C Reed
May 2, 2001·The Oncologist·S Waxman, K C Anderson
Jun 22, 2001·Leukemia·M V Blagosklonny
Aug 29, 2002·The Journal of Biological Chemistry·Hirohito Yamaguchi, Hong-Gang Wang
Sep 7, 2002·Antioxidants & Redox Signaling·Shugo UedaJunji Yodoi
Nov 29, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Martine Torres
Nov 25, 2003·Oncogene·Suzanne CoryJerry M Adams
Jan 28, 2004·Cell·Nika N Danial, Stanley J Korsmeyer
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wen-Chien ChouChi V Dang
Sep 25, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·An Van LaethemPatrizia Agostinis

❮ Previous
Next ❯

Citations

May 20, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Hui-Wen ChiuYing-Jan Wang
Apr 25, 2012·Archives of Toxicology·Ichiro YajimaMasashi Kato
Nov 3, 2009·Apoptosis : an International Journal on Programmed Cell Death·Nahed El-NajjarHala Gali-Muhtasib
Apr 11, 2009·World Journal of Gastroenterology : WJG·Jin-Shui PanJian-Lin Ren
Jun 24, 2014·Mitochondrion·Stephen Jun Fei ChongShazib Pervaiz
Jun 19, 2012·Journal of Endodontics·Mari FujisawaMitsuo Torii
Jan 8, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Limei XuZhaojian Liu
Aug 25, 2010·Pharmacology & Therapeutics·Gabriella LeonarduzziGiuseppe Poli
Mar 3, 2010·Toxicology and Applied Pharmacology·Daigo SumiYoshito Kumagai
Dec 31, 2008·Mutation Research·Rodrigo FrancoMihalis I Panayiotidis
Aug 28, 2010·Journal of Cellular Physiology·Ryoji EguchiTakashi Nakano
Mar 6, 2012·Phytotherapy Research : PTR·Shuli ManChangxiao Liu
Jan 22, 2011·British Journal of Pharmacology·Moon-Taek ParkHeon Joo Park
Jun 3, 2014·Journal of Experimental & Clinical Cancer Research : CR·Sanjay KumarPaul B Tchounwou
Jul 27, 2015·Current Opinion in Immunology·Shirley LuckhartCecilia Giulivi
Jan 13, 2015·International Journal of Oncology·Chun-Yan ZhengJames Chung-Man Ho
Jul 3, 2016·Archives of Oral Biology·Da Jeong KimYoung Whan Choi
Jan 19, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Daowen LiShusheng Tang
Aug 10, 2018·Journal of Biochemical and Molecular Toxicology·Sanjay KumarPaul B Tchounwou

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis